menu
    • menu

    Company profile for AEGIS Ltd. Cyprus

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AEGIS is a leading branded generic pharmaceutical company with a presence in more than 30 countries world-wide.AEGIS is dedicated to offer human pharmaceutical products that are proved to be therapeutically equivalent and interchangeable with those of the industry leaders.All products are EU approved, produced according to Good Manufacturing Practices at state-of-the-art facilities differentating them from ordinary generic pro...
    AEGIS is a leading branded generic pharmaceutical company with a presence in more than 30 countries world-wide.AEGIS is dedicated to offer human pharmaceutical products that are proved to be therapeutically equivalent and interchangeable with those of the industry leaders.All products are EU approved, produced according to Good Manufacturing Practices at state-of-the-art facilities differentating them from ordinary generic products.AEGIS cooperates with qualified partners who are able to maintain AEGIS' high EU standards.Through strategic partnerships, AEGIS is supported by state-of-the-art R&D facilities, capable of providing the latest molecules to be marketed immediately after the patent expiration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AEGIS Ltd. CyprusCyprus Flag
    Country
    Country
    Cyprus
    Address
    Address
    17 Athinon Street, Ergates Industrial Area, Nicosia, cyprus
    Telephone
    Telephone
    357 228 450 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.aegispharma.eu
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aegis, Northwell launch Optain for AI-powered disease detection
    Aegis, Northwell launch Optain for AI-powered disease detection

    09 May 2023

    // Andrea Park FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/aegis-northwells-optain-launches-12m-ai-powered-disease-detection

    Andrea Park FIERCE BIOTECH
    09 May 2023
    Share Share
    RDIF & Wockhardt partner to produce Sputnik V and Sputnik Light
    RDIF & Wockhardt partner to produce Sputnik V and Sputnik Light

    13 Aug 2021

    // LIVEMINT

    https://www.livemint.com/companies/news/rdif-wockhardt-partner-to-produce-sputnik-v-and-sputnik-light-vaccines-11628856999410.html

    LIVEMINT
    13 Aug 2021
    Share Share
    Aegis Launches COVID-19 Testing Program for Schools
    Aegis Launches COVID-19 Testing Program for Schools

    10 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210610005865/en

    BUSINESSWIRE
    10 Jun 2021
    Share Share
    Aegis Life Announces Start of Phase 1/2 Trial of the Entos COVID-19 DNA Vaccine
    Aegis Life Announces Start of Phase 1/2 Trial of the Entos COVID-19 DNA Vaccine

    16 Apr 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210416005430/en

    BUSINESSWIRE
    16 Apr 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search